PROF - Profound Medical Corp logo

Profound Medical Corp

PROF

Profound Medical Corp develops AI-powered, MRI-guided systems for incision-free ablation of diseased tissue, focusing on prostate cancer with its TULSA-PRO system and treating uterine fibroids and bone metastases with Sonalleve, operating globally.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 10 years ago โ†’$725today

Score Overview

1 Year
Score
Net Growth24.63%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth16.07%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score6.5
Net Growth-6.35%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth176.62%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-168.77%
Net Trend60%
Net Income Consistency
Rev Growthโ€”
Rev Trend70%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-168.77%
Net Trend60%
Net Income Consistency
Rev Growthโ€”
Rev Trend70%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Profound Medical Corp has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PROF does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-22
$ 5.76โ€”
1 Year2025-10-22
$ 5.426.27%
5 Years2021-10-22
$ 14.36-59.89%
10 Years2016-10-19
$ 7.95-27.55%
All Time2016-06-09
$ 10.19-43.45%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 19M-$ 32M$ 38M
2025$ 16M-$ 43M$ 81M
2024$ 10M-$ 26M$ 54M
2023$ 7M-$ 28M$ 26M
2022$ 6M-$ 28M$ 46M
2021$ 6M-$ 30M$ 67M
2020$ 7M-$ 21M$ 83M
2019$ 4M-$ 15M$ 14M
2018$ 1M-$ 15M$ 22M
2017$ 4M-$ 19M$ 8M
IPO2016$ 0.00-$ 12M$ 15M
PROF - Profound Medical Corp logo

Profound Medical Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 7M to $ 16M and net income went from -$ 21M to -$ 43M. Revenue increased in 4 of those 5 years; net income in 4.

Profound Medical Corp currently holds a 5-year HDB Score of 6.5 out of 10. How the HDB Score is calculated.

Membership

Explore PROF with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,119 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies